Literature DB >> 31682457

Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.

Anna Mantsiou1, Manousos Makridakis1, Konstantinos Fasoulakis2, Ioannis Katafigiotis3, Constantinos A Constantinides3, Jerome Zoidakis1, Maria G Roubelakis4, Antonia Vlahou1, Vasiliki Lygirou1.   

Abstract

Prostate cancer (PCa) is one of the leading causes of death in men worldwide. The molecular features, associated with the onset and progression of the disease, are under vigorous investigation. Formalin-fixed paraffin-embedded (FFPE) tissues are valuable resources for large-scale studies; however, their application in proteomics is limited due to protein cross-linking. In this study, the adjustment of a protocol for the proteomic analysis of FFPE tissues was performed which was followed by a pilot application on FFPE PCa clinical samples to investigate whether the optimized protocol can provide biologically relevant data for the investigation of PCa. For the optimization, FFPE mouse tissues were processed using seven protein extraction protocols including combinations of homogenization methods (beads, sonication, boiling) and buffers (SDS based and urea-thiourea based). The proteome extraction efficacy was then evaluated based on protein identifications and reproducibility using SDS electrophoresis and high resolution LC-MS/MS analysis. Comparison between the FFPE and matched fresh frozen (FF) tissues, using an optimized protocol involving protein extraction with an SDS-based buffer following beads homogenization and boiling, showed a substantial overlap in protein identifications with a strong correlation in relative abundances (rs = 0.819, p < 0.001). Next, FFPE tissues (3 sections, 15 μm each per sample) from 10 patients with PCa corresponding to tumor (GS = 6 or GS ≥ 8) and adjacent benign regions were processed with the optimized protocol. Extracted proteins were analyzed by GeLC-MS/MS followed by statistical and bioinformatics analysis. Proteins significantly deregulated between PCa GS ≥ 8 and PCa GS = 6 represented extracellular matrix organization, gluconeogenesis, and phosphorylation pathways. Proteins deregulated between cancerous and adjacent benign tissues, reflected increased translation, peptide synthesis, and protein metabolism in the former, which is consistent with the literature. In conclusion, the results support the relevance of the proteomic findings in the context of PCa and the reliability of the optimized protocol for proteomics analysis of FFPE material.

Entities:  

Keywords:  FFPE; LC-MS/MS; prostate cancer; proteomics; protocol adjustment

Mesh:

Substances:

Year:  2019        PMID: 31682457     DOI: 10.1021/acs.jproteome.9b00587

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panels.

Authors:  Qing Kay Li; Tung-Shing Mamie Lih; Yuefan Wang; Yingwei Hu; Naseruddin Höti; Daniel W Chan; Hui Zhang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy.

Authors:  Georgios Barkas; Manousos Makridakis; Hariklia Gakiopoulou; Demetrios Vlahakos
Journal:  Data Brief       Date:  2022-01-06

3.  Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.

Authors:  Qing Kay Li; Jing Chen; Yingwei Hu; Naseruddin Höti; Tung-Shing Mamie Lih; Stefani N Thomas; Li Chen; Sujayita Roy; Alan Meeker; Punit Shah; Lijun Chen; G Steven Bova; Bai Zhang; Hui Zhang
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

4.  Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.

Authors:  Shiyu Tong; Hongling Yin; Jun Fu; Yangle Li
Journal:  J Cancer       Date:  2022-01-09       Impact factor: 4.207

5.  Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.

Authors:  Vasiliki Lygirou; Konstantinos Fasoulakis; Rafael Stroggilos; Manousos Makridakis; Agnieszka Latosinska; Maria Frantzi; Ioannis Katafigiotis; Christos Alamanis; Konstantinos G Stravodimos; Constantinos A Constantinides; Antonia Vlahou; Jerome Zoidakis
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

Review 6.  Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction.

Authors:  Nutnicha Sirikaew; Dumnoensun Pruksakorn; Parunya Chaiyawat; Somchai Chutipongtanate
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

7.  From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.

Authors:  Tang Biao; He Cai-Feng; Lu Xiao-Hong; Chang Xiao-Li; Liu Wen-Bei; Wang Jun; Ci Chao; Yuan Tao
Journal:  J Transl Med       Date:  2022-09-09       Impact factor: 8.440

8.  Quantitative Proteomics Analysis of FFPE Tumor Samples Reveals the Influences of NET-1 siRNA Nanoparticles and Sonodynamic Therapy on Tetraspanin Protein Involved in HCC.

Authors:  Bolin Wu; Haitao Shang; Jiayin Liu; Xitian Liang; Yanchi Yuan; Yichi Chen; Chunyue Wang; Hui Jing; Wen Cheng
Journal:  Front Mol Biosci       Date:  2021-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.